pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
C4 Therapeutics, Inc. ($CCCC) · catalysts · pharmadog
← back to C4 Therapeutics, Inc.
Catalysts for $CCCC
3
tracked
Nov 21, 2025
approval
9mo ago
UNLOXCYT (COSIBELIMAB-IPDL) — FDA approval
cosibelimab
→
Dec 13, 2024
approval
2y ago
UNLOXCYT (COSIBELIMAB-IPDL) — FDA approval
cosibelimab
→
RECRUITING
phase readout
NCT06778863: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
C4 Therapeutics, Inc.
→
$CCCC
$CCCC
$CCCC
